$20.29
0.74%
Downside
Day's Volatility :1.42%
Upside
0.69%
21.59%
Downside
52 Weeks Volatility :38.69%
Upside
21.81%
Period | Fresenius Medical Care Ag | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | 1.44% | 6.5% | 0.0% |
6 Months | 1.59% | 7.1% | 0.0% |
1 Year | -22.77% | 9.8% | 0.0% |
3 Years | -49.63% | 14.2% | -20.2% |
Market Capitalization | 11.9B |
Book Value | $47.4 |
Dividend Share | 1.19 |
Dividend Yield | 3.19% |
Earnings Per Share (EPS) | 0.9 |
PE Ratio | 22.58 |
PEG Ratio | 0.39 |
Wall Street Target Price | 19.52 |
Profit Margin | 2.48% |
Operating Margin TTM | 7.65% |
Return On Assets TTM | 2.83% |
Return On Equity TTM | 4.72% |
Revenue TTM | 19.5B |
Revenue Per Share TTM | 33.19 |
Quarterly Revenue Growth YOY | 0.4% |
Gross Profit TTM | 5.3B |
EBITDA | 2.5B |
Diluted Eps TTM | 0.9 |
Quarterly Earnings Growth YOY | -0.17 |
EPS Estimate Current Year | 1.5 |
EPS Estimate Next Year | 1.95 |
EPS Estimate Current Quarter | 0.26 |
EPS Estimate Next Quarter | 0.37 |
What analysts predicted
Downside of 3.79%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 18.9B | ↓ 6.96% |
Net Income | 2.3B | ↑ 54.84% |
Net Profit Margin | 11.98% | ↑ 4.78% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 19.6B | ↑ 5.62% |
Net Income | 1.3B | ↓ 39.46% |
Net Profit Margin | 6.87% | ↓ 5.11% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 22.0B | ↑ 2.19% |
Net Income | 1.4B | ↓ 2.97% |
Net Profit Margin | 6.52% | ↓ 0.35% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 20.0B | ↓ 1.34% |
Net Income | 1.1B | ↓ 16.75% |
Net Profit Margin | 5.5% | ↓ 1.02% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 20.8B | ↑ 10.1% |
Net Income | 721.4M | ↓ 30.53% |
Net Profit Margin | 3.47% | ↓ 2.03% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 19.5B | ↑ 0.29% |
Net Income | 499.0M | ↓ 25.9% |
Net Profit Margin | 2.57% | ↓ 0.9% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 5.4B | ↓ 1.95% |
Net Income | 207.8M | ↓ 15.69% |
Net Profit Margin | 3.88% | ↓ 0.64% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 5.1B | ↓ 5.86% |
Net Income | 146.0M | ↓ 31.0% |
Net Profit Margin | 2.85% | ↓ 1.03% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 5.3B | ↑ 2.57% |
Net Income | 153.1M | ↑ 4.86% |
Net Profit Margin | 2.91% | ↑ 0.06% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 4.9B | ↑ 2.3% |
Net Income | 84.4M | ↓ 39.9% |
Net Profit Margin | 1.71% | ↓ 1.2% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 5.0B | ↑ 1.05% |
Net Income | 187.9M | ↑ 122.79% |
Net Profit Margin | 3.77% | ↑ 2.06% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 5.1B | ↓ 5.27% |
Net Income | 76.6M | ↓ 62.24% |
Net Profit Margin | 1.5% | ↓ 2.27% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 30.0B | ↑ 9.23% |
Total Liabilities | 15.3B | ↑ 1.08% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 36.9B | ↑ 25.5% |
Total Liabilities | 22.1B | ↑ 47.74% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 39.0B | ↓ 3.78% |
Total Liabilities | 23.8B | ↓ 1.78% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 38.9B | ↑ 8.45% |
Total Liabilities | 23.1B | ↑ 5.32% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 38.3B | ↑ 4.04% |
Total Liabilities | 21.8B | ↓ 0.41% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 33.9B | ↓ 5.1% |
Total Liabilities | 19.1B | ↓ 5.92% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 38.3B | ↓ 6.91% |
Total Liabilities | 21.8B | ↓ 6.3% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 38.1B | ↓ 2.22% |
Total Liabilities | 21.8B | ↓ 1.35% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 38.1B | ↑ 0.0% |
Total Liabilities | 21.9B | ↑ 0.0% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 35.6B | ↑ 1.93% |
Total Liabilities | 20.2B | ↑ 0.85% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 33.9B | ↓ 4.78% |
Total Liabilities | 19.1B | ↓ 5.43% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 37.1B | ↑ 1.2% |
Total Liabilities | 20.7B | ↑ 0.53% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 2.4B | ↓ 5.93% |
Investing Cash Flow | -280.3M | ↓ 75.29% |
Financing Cash Flow | -779.9M | ↓ 14.64% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 2.9B | ↑ 24.49% |
Investing Cash Flow | -3.7B | ↑ 1241.01% |
Financing Cash Flow | -522.7M | ↓ 31.55% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 5.2B | ↑ 64.9% |
Investing Cash Flow | -1.6B | ↓ 59.37% |
Financing Cash Flow | -3.3B | ↑ 470.9% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 2.8B | ↓ 41.2% |
Investing Cash Flow | -1.4B | ↓ 10.39% |
Financing Cash Flow | -1.2B | ↓ 61.55% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 2.3B | ↓ 12.94% |
Investing Cash Flow | -787.1M | ↓ 38.58% |
Financing Cash Flow | -1.7B | ↑ 57.89% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 642.7M | ↓ 8.76% |
Investing Cash Flow | -787.1M | ↑ 628.95% |
Financing Cash Flow | -128.5M | ↓ 76.14% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 155.8M | ↓ 76.19% |
Investing Cash Flow | -178.1M | ↓ 77.78% |
Financing Cash Flow | 2.2M | ↓ 101.68% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 1.1B | ↑ 605.11% |
Investing Cash Flow | -323.6M | ↑ 81.67% |
Financing Cash Flow | -766.6M | ↓ 34983.76% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 759.8M | ↓ 24.56% |
Investing Cash Flow | -447.7M | ↑ 50.94% |
Financing Cash Flow | -412.3M | ↓ 41.31% |
Sell
Neutral
Buy
Fresenius Medical Care Ag is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Fresenius Medical Care Ag | 6.75% | 1.59% | -22.77% | -49.63% | -45.76% |
Hca Holdings, Inc. | 3.62% | 24.47% | 25.02% | 43.55% | 143.2% |
Tenet Healthcare Corp. | 10.35% | 80.65% | 95.1% | 108.93% | 580.33% |
Universal Health Services Inc. | 8.08% | 30.09% | 44.94% | 32.59% | 34.96% |
Davita Healthcare Partners Inc. | 0.24% | 32.97% | 40.81% | 19.01% | 139.9% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Fresenius Medical Care Ag | 22.58 | 22.58 | 0.39 | 1.5 | 0.05 | 0.03 | 0.03 | 47.4 |
Hca Holdings, Inc. | 16.16 | 16.16 | 1.44 | 21.86 | 0.74 | 0.11 | 0.01 | -6.06 |
Tenet Healthcare Corp. | 5.46 | 5.46 | 1.74 | 8.98 | 0.54 | 0.07 | NA | 16.09 |
Universal Health Services Inc. | 15.8 | 15.8 | 1.87 | 13.79 | 0.13 | 0.06 | 0.0 | 93.48 |
Davita Healthcare Partners Inc. | 16.31 | 16.31 | 1.16 | 9.32 | 0.43 | 0.06 | NA | 10.56 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Fresenius Medical Care Ag | Hold | $11.9B | -45.76% | 22.58 | 2.48% |
Hca Holdings, Inc. | Buy | $90.1B | 143.2% | 16.16 | 8.4% |
Tenet Healthcare Corp. | Buy | $14.6B | 580.33% | 5.46 | 12.54% |
Universal Health Services Inc. | Hold | $12.4B | 34.96% | 15.8 | 5.57% |
Davita Healthcare Partners Inc. | Hold | $12.6B | 139.9% | 16.31 | 6.61% |
Insights on Fresenius Medical Care Ag
Revenue is down for the last 2 quarters, 4.98B → 4.72B (in $), with an average decrease of 5.3% per quarter
Netprofit is down for the last 2 quarters, 187.92M → 70.95M (in $), with an average decrease of 62.2% per quarter
In the last 1 year, Tenet Healthcare Corp. has given 95.1% return, outperforming this stock by 117.9%
In the last 3 years, Tenet Healthcare Corp. has given 108.9% return, outperforming this stock by 158.5%
Pzena Investment Management, LLC
Fiduciary Management, Inc. of Milwaukee
Dodge & Cox
Morgan Stanley - Brokerage Accounts
Goldman Sachs Group Inc
Pacer Advisors, INC.
In the quarter ending September,2024. Fresenius Medical Care Ag has declared dividend of $0.63
Read MoreFresenius Medical Care AG & Co. KGaA is an American German healthcare company which provides kidney dialysis services.
Organization | Fresenius Medical Care Ag |
Employees | 117128 |
CEO | Ms. Helen Giza |
Industry | Health Services |